Robert J - Search Results

1

Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies.

Del Rio M, Mollevi C, Bibeau F, Vie N, Selves J, Emile JF, Roger P, Gongora C, Robert J, Tubiana-Mathieu N, Ychou M, Martineau P. Del Rio M, et al. Among authors: robert j. Eur J Cancer. 2017 May;76:68-75. doi: 10.1016/j.ejca.2017.02.003. Epub 2017 Mar 8. Eur J Cancer. 2017. PMID: 28284171

2

First-in-man phase I study assessing the safety and pharmacokinetics of a 1-hour intravenous infusion of the doxorubicin prodrug DTS-201 every 3 weeks in patients with advanced or metastatic solid tumours.

Schöffski P, Delord JP, Brain E, Robert J, Dumez H, Gasmi J, Trouet A. Schöffski P, et al. Among authors: robert j. Eur J Cancer. 2017 Nov;86:240-247. doi: 10.1016/j.ejca.2017.09.009. Epub 2017 Oct 19. Eur J Cancer. 2017. PMID: 29055839 Clinical Trial.

3

[5-FU: At last!].

Robert J. Robert J. Bull Cancer. 2019 Mar;106(3):173-174. doi: 10.1016/j.bulcan.2019.02.001. Bull Cancer. 2019. PMID: 30837157 French. No abstract available.

4

Individual dose adaptation of anticancer drugs.

Desoize B, Robert J. Desoize B, et al. Among authors: robert j. Eur J Cancer. 1994;30A(6):844-51. doi: 10.1016/0959-8049(94)90304-2. Eur J Cancer. 1994. PMID: 7917547 Review.

5

[About the reimbursement of tests predictive of metastatic relapse in operated breast cancers].

Robert J. Robert J. Bull Cancer. 2019 Apr;106(4):279-280. doi: 10.1016/j.bulcan.2019.03.001. Bull Cancer. 2019. PMID: 30955712 French. No abstract available.

6

[Immunotherapy: From basic research to patient treatment - A 2018 Nobel Jury recognition].

Robert J. Robert J. Bull Cancer. 2018 Oct;105(10):851-852. doi: 10.1016/j.bulcan.2018.10.001. Bull Cancer. 2018. PMID: 30343690 French. No abstract available.

7

Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.

Robert J. Robert J. J Chemother. 2004 Nov;16 Suppl 4:22-4. doi: 10.1179/joc.2004.16.Supplement-1.22. J Chemother. 2004. PMID: 15688604 Review.

8

[Pharmacogenetics and pharmacogenomics of cancers].

Robert J. Robert J. Pathol Biol (Paris). 2004 Jul;52(6):332-7. doi: 10.1016/j.patbio.2003.09.016. Pathol Biol (Paris). 2004. PMID: 15261376 Review. French.

9

Approaches to multidrug resistance reversal.

Robert J. Robert J. Expert Opin Investig Drugs. 1998 Jun;7(6):929-39. doi: 10.1517/13543784.7.6.929. Expert Opin Investig Drugs. 1998. PMID: 15992007

10

MS-209 Schering.

Robert J. Robert J. Curr Opin Investig Drugs. 2004 Dec;5(12):1340-7. Curr Opin Investig Drugs. 2004. PMID: 15648956 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,192 results

Search Page

Filters